Engineering for new heights in the treatment of IBD and beyond
![A 3D visualization of a skyline with X, Y, Z]](https://cdn.prod.website-files.com/68163046112b61d49275fcec/682f14d59cdb54b9458f74b1_d05fb1ec5c3279929ba68a28bc590bc5_sptx_0-1_v1_final_1_frame_0_x2.avif)
![A 3D visualization of a skyline with X, Y, Z]](https://cdn.prod.website-files.com/68163046112b61d49275fcec/682f14d5b74b08de3e283cf6_7af02809e1f36fd8559235c4efcd24c3_sptx_0-1_v1_mobile_final_1_frame_0_x2.avif)
Our Approach
Spyre is developing next-generation antibodies that are engineered for prolonged activity in the body and formulated for delivery as monotherapies or combination therapies. Our innovative approach enables the exploration of treatment options with the potential to deliver uncompromising efficacy and convenience.
Our pipeline
Our pipeline of novel antibodies target validated mechanisms with the potential to treat several gastrointestinal and rheumatic conditions.
Our commitment to patients
We are committed to transforming the lives of patients and caregivers through our mission to develop improved treatment options for IBD and other immune-mediated diseases.
Join Us
We are a collaborative and interdisciplinary team. If you are passionate about making a tangible difference and thrive in a dynamic environment, we invite you to apply to join our pioneering organization.
ABOUT US
Our team has deep experience developing and commercializing treatments across a broad
range of diseases, and is committed to improving the lives of patients.
News & Updates
